(Q37716042)

English

Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations

scientific article published on March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

1 reference

Europe PubMed Central

Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

1 reference

based on heuristic

inferred from title

author name string

Douglas B Muchmore

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Daniel E Vaughn

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

publication date

1 March 2010

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Journal of Diabetes Science and Technology

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

419-428

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Absorption kinetics of insulin after subcutaneous administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

23 August 2017

Clinical pharmacokinetics and pharmacodynamics of insulin glulisine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

23 August 2017

Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

23 August 2017

Hyaluronidase; a review of its therapeutic use in pediatrics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

23 August 2017

Clinical pharmacokinetics and pharmacodynamics of insulin aspart

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

23 August 2017

Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

23 June 2018

Subcutaneous fluid administration in elderly subjects: validation of an under-used technique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

23 June 2018

The INFUSE-Morphine IIB study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneous morphine in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

The INFUSE-Morphine study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneously administered morphine in patients with advanced illness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Efficacy and safety of hyaluronidase 75 IU as an adjuvant to mepivacaine for retrobulbar anesthesia in cataract surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

A novel insulin formulation with a more rapid onset of action.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Standards of medical care in diabetes--2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Assessing the role of human recombinant hyaluronidase in gravity-driven subcutaneous hydration: the INFUSE-LR study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Insulin glulisine: a faster onset of action compared with insulin lispro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

The effect of hyaluronidase on ultrasound-measured dispersal of local anaesthetic following sub-Tenon injection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864178

1 September 2018

Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-reported factors that affect glycemic control in college students with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of hyaluronidase on the subcutaneous absorption of electrolytes in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A recombinant human enzyme for enhanced interstitial transport of therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment and implication of the allergic sensitivity to a single dose of recombinant human hyaluronidase injection: a double-blind, placebo-controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical observations on the use of hyaluronidase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20307403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/193229681000400223

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37716042&oldid=2141644520"